Modern medicine's laser focus on specialties is leaving complex patients behind. Across Europe, people with rare, chronic, and multisystemic conditions are forced to self-coordinate fragmented care — a burden that's both physically exhausting and financially costly. Experts say a shift to integrated, person-centered care isn't just humane; it's economically smarter.
Modern medicine's obsession with specialization has a dark side: patients with complex, multisystemic conditions are increasingly falling through the cracks. Across Europe, people living with rare or chronic diseases — like Ehlers-Danlos syndrome, lupus, or Sjögren disease — are left to act as unpaid project managers of their own care, shuttling between specialists who rarely talk to each other, repeating their histories, and absorbing the cost of redundant tests and dangerous drug interactions.
The problem hits hardest for women and marginalized groups. Women face higher rates of autoimmune and rare diseases, yet hormonal shifts that can alter disease activity are rarely factored into cross-specialty care plans. For gender-diverse patients, fragmented care adds another layer — finding a specialist who is both clinically expert and affirming can mean traveling across countries for routine screenings.
Economists and health researchers warn this isn't just a compassion failure — it's a financial one. Siloed systems default to expensive, reactive emergency care instead of cheaper preventive interventions, creating a mounting "care debt."
Key Takeaways:
Why it matters: Fragmented care isn't just an inconvenience — it costs lives and money. Research from the International Foundation for Integrated Care shows that person-centered models save costs long-term, but systemic inertia keeps many health systems stuck in siloed, reactive care. The fix exists; the will to implement it is what's missing.
